Bai M, Li J, Liu L, et al. Risk factors and clinical features of hepatic hydrothorax: insights from a single-centre cohort. Front Med (Lausanne). 2023;10:1165604.
Gomez-Herrera J, Carrillo-Bayona JA, Londoño-Burbano A, et al. Hepatic Hydrothorax worsens outcomes in cirrhosis: a retrospective study. J Clin Med. 2023;12(1):212.
Wilkins H, Britt E, Bhatnagar M, Pippard B. Hepatic hydrothorax. J Thorac Dis. 2024;16(4):1662–71.
Article PubMed PubMed Central Google Scholar
Cadranel JF, Ollivier-Hourmand I, Cadranel J, et al. International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations. BMC Gastroenterol. 2023;23(1):305.
Article PubMed PubMed Central CAS Google Scholar
Banini BA, Alwatari Y, Stovall M, et al. Multidisciplinary management of hepatic hydrothorax in 2020: an evidence-based review and guidance. Hepatology. 2020;72(5):1851–63.
Vidyani A, Sibarani CI, Widodo B, et al. Diagnosis and management of hepatic hydrothorax. Korean J Gastroenterol. 2024;83(2):45–53.
Gao Y, Wang X, Chen L, et al. Spontaneous bacterial empyema in patients with hepatic hydrothorax: incidence, risk factors, and outcomes. Clin Res Hepatol Gastroenterol. 2021;45(3):101503.
Hooper C, Lee YCG, Maskell N. Investigation of a unilateral pleural effusion in adults: British thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii4–17.
Hallifax RJ, Rahman NM. Modern management of pleural effusions. BMJ. 2017;358:j3440.
European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60.
Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin Pulm Med. 1998;4(4):239–43.
Article PubMed CAS Google Scholar
Bernardi M, Moreau R, Angeli P, et al. Albumin infusion in patients with cirrhosis: where are we now and what’s next? JHEP Rep. 2023;5(8):100749.
Morando F, Rosi S, Gola E, et al. Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. Liver Int. 2015;35(5):1508–15.
Article PubMed CAS Google Scholar
Fogel MR, Sawhney VK, Neal EA, et al. Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol. 1981;3(Suppl 1):73–80.
Sawhney VK, Gregory PB, Swezey SE, Blaschke TF. Furosemide disposition in cirrhotic patients. Gastroenterology. 1981;81(6):1012–6.
Article PubMed CAS Google Scholar
Daskalopoulos G, Laffi G, Morgan T, et al. Immediate effects of Furosemide on renal hemodynamics in chronic liver disease with Ascites. Gastroenterology. 1987;92(7):1859–65.
Article PubMed CAS Google Scholar
Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117(3):215–20.
Article PubMed CAS Google Scholar
Spahr L, Villeneuve JP, Tran HK, Pomier-Layrargues G. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites. Hepatology. 2001;33(1):28–32.
Article PubMed CAS Google Scholar
Pockros PJ, Reynolds TB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology. 1986;90(6):1827–33.
Article PubMed CAS Google Scholar
Pippard B, Britt E, Wilkins H, Bhatnagar M. Hepatic hydrothorax: a narrative review. Pulm Ther. 2022;8(2):241–54.
Article PubMed PubMed Central Google Scholar
Gilbert CR, Shojaee S, Maldonado F, et al. Pleural interventions in the management of hepatic hydrothorax. Chest. 2022;161(1):276–83.
Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med. 2010;170(4):332–9.
McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31(2):164–71.
Article PubMed CAS Google Scholar
Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine (Baltimore). 2014;93(3):135–42.
Sobotka LA, Spitzer C, Hinton A, et al. Management of hepatic hydrothorax and effect on length of stay, mortality, cost, and 30-day hospital readmission. J Gastroenterol Hepatol. 2020;35(4):641–7.
Chin A, Bastaich DR, Dahman B, et al. Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites. Hepatology. 2024;79:844–56.
Gou X, Jia W, He C, et al. Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients. Eur Radiol. 2023;33:3407–15.
Osman KT, Naritsin A, Amuchi B, Qamar AA. Liver transplantation for refractory hepatic hydrothorax is associated with a greater survival benefit compared to other complications of cirrhosis. Liver Transpl. 2024;30:142–50.
Thevenot T, Raevens S, Aujayeb A, et al. Pulmonary complications of advanced chronic liver diseases: an updated review. Explor Dig Dis. 2024;3:301–25.
Chen A, Shojaee S, Ost D, Christophi C, Musto P, Eapen GA. Use of indwelling tunneled pleural catheters for the management of hepatic hydrothorax. Chest. 2016;149(2):R3867.
Wang Z, Xu L, Wang W, et al. Indwelling pleural catheter for hepatic hydrothorax: a systematic review. Clin Respir J. 2018;12(10):2670–8.
Kniese C, Boffa DJ, Rickert A, Arnaoutakis G, Kim AW, Detterbeck FC. Indwelling pleural catheters in the management of hepatic hydrothorax: a 10-year single-centre experience. J Surg Res. 2019;234:8–13.
Avula A, Parasa S, Gaddam S, et al. Indwelling pleural catheter (IPC) for the management of hepatic hydrothorax: a systematic review and meta-analysis. J Bronchol Interv Pulmonol. 2022;29(3):194–202.
Walker SP, Bintcliffe O, Keenan E, et al. Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions. Eur Respir J. 2022;59(2):2201276.
Thøgersen A, Kristiansen B, Løkke A, Hilberg O, Borg M. Indwelling peritoneal and pleural catheters in the management of malignant and non-malignant ascites and pleural effusion: experiences from a Danish tertiary center. Eur Clin Respir J. 2025;12(1):2529053. https://doi.org/10.1080/20018525.2025.2529053.
Article PubMed PubMed Central Google Scholar
Strauss RM, Boyer TD. The use of chemical pleurodesis in the management of hepatic hydrothorax: a pilot study. Am J Gastroenterol. 1994;89(8):1520–2.
Kalomenidis I, Milionis H, Dimopoulou I, et al. Talc pleurodesis in hepatic hydrothorax: efficacy and safety. Respiration. 2006;73(6):801–5.
Kim Y, Kim HJ, Lee HJ, et al. Management of hepatic Hydrothorax using video-assisted thoracoscopic surgery and pleurodesis: a single-centre experience. Clin Mol Hepatol. 2012;18(3):258–64.
Lee HJ, Kim Y, Lee YS, et al. Outcomes of Talc pleurodesis for hepatic Hydrothorax in cirrhotic patients undergoing thoracoscopy. Clin Mol Hepatol. 2012;18(3):258–64.
Comments (0)